Skip to main content
Market intelligence
DYNHealthcare

Dyne Therapeutics Inc insider activity

In the last 90 days, 1 corporate insider purchased $156,800 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$156,800
Corporate buyers
1
Latest transaction
Jun 25, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 25, 2026Jason P RhodesDirectorSale267,760$21.09$5,646,496
Jun 25, 2026Erick LuceraChief Financial OfficerSale2,362$20.37$48,114
Jun 23, 2026Dirk KerstenDirectorSale263,962$20.70$5,464,621